Oncobiologics Inc. , a biotechnology company, was trading at $4.81 Friday on its first day of trade, below its issue price of $6. The company sold 5.8 million units lat Thursday to raise about $34.8 million. Each unit is made up of one share of common stock, one-half of a Series A warrant and one-half of a Series B warrant. The common stock, series A and series B warrants are trading separately on the Nasdaq under the symbols “ONS,” “ONSIW” and “ONSIZ.” Jefferies and Barclays acted as the lead underwriters.
Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.
From:: Stock Market News